Skip to main content
Clinical Trials/CTRI/2017/09/009851
CTRI/2017/09/009851
Completed
Phase 4

Recurrence of dermatophytosis and therapeutic efficacy of systemic antifungals in adults â?? A randomized, open-label controlled trial in a tertiary institution.

Chinmay Kar0 sites155 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: null- DermatophytosisHealth Condition 2: B359- Dermatophytosis, unspecified
Sponsor
Chinmay Kar
Enrollment
155
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
October 5, 2018
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Chinmay Kar

Eligibility Criteria

Inclusion Criteria

  • (1\) Adult patients (15\-60 years) with recurrent tinea corporis, cruris or faciei or combinations of these attending our Dermatology OPD, will be the candidates of this study. Most of them present with an extensive form.
  • (2\) They have a history of Cap Itraconazole intake (100mg twice daily for at least one month) without interruption and re\-occurrence of similar form of tinea after stopping Itraconazole within a short period (one week to six weeks).
  • (3\) They must have normal blood count, liver and renal function tests.
  • (4\) Positive KOH smear on skin scraping.
  • (5\) Regular follow up is possible and complied with to note the improvement and/or any other complications.

Exclusion Criteria

  • (1\)Patients with Diabetes Mellitus or other immunocompromised disorders.
  • (2\)Patients with H/O steroid or immunosuppressant medicines intake.
  • (3\) Pregnant or lactating mother.
  • (4\) Other family members will have chronic tinea infections.
  • (5\) Patients with other form of tinea infection like tinea pedis, tinea manuum, tinea unguium etc.

Outcomes

Primary Outcomes

Not specified

Similar Trials